The feline T-cell lymphotropic lentivirus (feline immunodeficiency virus) is a recently described felinespecific retrovirus that can produce chronic immunodeficiency-like disorders in cats. A microdilution plate format enzyme-linked immunosorbent assay has been developed to detect the presence of antibody to the virus in feline serum or plasma. Temporal studies performed with experimentally infected animals show that seroconversion can be demonstrated 3 to 4 weeks after exposure to the virus. Results of a serosurvey (n = 1,556 samples) indicate that infection is fairly common in both clinic (5.2%) and sick cat (15.2%) populations. Western blot (immunoblot) and sodium dodecyl sulfate radioimmunoprecipitation assays were developed to confirm microdilution plate test results and to identify peptides specific for the feline immunodeficiency virus. All microdilution plate test positive results and selected negative results were confirmed by one or both of these procedures. These data demonstrate that this microassay plate enzyme-linked immunosorbent assay is a very sensitive and specific test for detection of antibody to the feline immunodeficiency virus.
A recently identified retrovirus has been shown to be the causitive agent of a chronic immunodeficiency-like syndrome in cats (21) . In initial reports the virus was named feline T-lymphotropic lentivirus to reflect the tropism of the virus for feline T cells and the classification of the agent as a member of the lentivirus subfamily of retroviruses (12, 22) . The name of the virus has been recently changed to feline immunodeficiency virus (FIV) to conform with international nomenclature for immunodeficiency-linked viruses (24) . The FIV agent has a strong but not absolute tropism for the feline T-lymphocyte cell line, which may be responsible for the immunosuppressive nature of the virus. Viral particle morphology and the Mg2+ metal requirement of the viral reverse transcriptase are supportive of the classification of the virus as a lentivirus.
The virus is distinct from previously described feline retroviruses and represents the first report of a feline-specific lentivirus (21) . Members of the lentivirus subfamily infecting other species include the human immunodeficiency virus (HIV) (8, 15) , visna virus in sheep (19) , caprine arthritisencephalitis virus (7), equine infectious anemia virus (20) , bovine immunodeficiency virus (9), and simian immunodeficiency virus (3).
The clinical course of FIV infection appears to be characterized by a lengthy asymptomatic phase persisting several months or perhaps years, during which viral infection can be demonstrated but clinical symptoms are not apparent (24) . This period of apparent viral latency is typical of lentiviral infections and frequently precedes the development of clinical abnormalities (10). Clinical symptoms most commonly associated with FIV infection include rhinitis and gingivitis, anemia, diarrhea, pustular dermatitis, and generalized lymphadenopathy (12, 22 The FIV is infectious within feline populations and can be transmitted after intimate and prolonged contact. Initial reports suggest that biting may be an important mode of viral transmission (24) . Isolates of FIV have been identified in the United States (21), the United Kingdom (11), and Japan (13) . A limited serosurvey in the United States reported that 1 in 18 healthy cats and 10 of 25 unhealthy cats were seropositive for FIV infection (21) .
The continuous propagation of FIV in an established Crandell feline cell line has permitted the isolation and purification of large quantities of virus. The highly purified virus was used to develop a sensitive microdilution platebased enzyme-linked immunosorbent assay (ELISA) for detection of feline antibody specific for the FIV agent. In this report we describe the development of the FIV microdilution plate ELISA, partially characterize immunoreactive viral peptides, and present data on the prevalence of viral infection in several populations (n = 1,556). The results of this survey demonstrate that FIV infection is relatively common and widespread in the United States.
MATERIALS AND METHODS
Virus and cell culture. The FIV was propagated in chronically infected Crandell feline kidney (Crfk) cells (6). The virus was concentrated from tissue culture fluids by precipitation with polyethylene glycol (4) and purified by density gradient centrifugation on glycerol gradients as previously described (18).
The FIV microdilution plates were prepared by coating microdilution wells with 100 ,ul of an inactivated detergentdisrupted preparation of FIV antigen (5.0 ,ug/ml). Samples of feline serum or plasma were diluted (1:100) in 20 mM sodium phosphate-150 mM NaCl (pH 7.4) containing calf serum and bovine serum albumin. Diluted samples (100 pt) were ap-IMMUNOASSAY FOR ANTIBODIES TO FIV 475 plied to individual microdilution wells and incubated for 30 min at room temperature. The contents of the microdilution plates were aspirated, and the plates were washed (five times) and incubated (30 min, room temperature) with goat anti-feline horseradish peroxidase conjugate (Kirkegaard and Perry). The contents of the microdilution plates were aspirated, the plates were washed (five times), and substrate solution (100 ,ul) was added. The substrate solution was prepared immediately before the assay by mixing equivolume portions of 0.1% 3,3',5,5'-tetramethylbenzidine in 60% methanol-40% glycerol with 0.04% hydrogen peroxide in 0.1 M dibasic potassium phosphate-citrate (pH 4.8) containing 0.01% Thimerosal. The enzymatic reaction was carried out for 15 min at room temperature and then stopped by addition of 100 ,ul of dilute hydrofluoric acid solution (1:400). Individual microdilution well optical density values were determined spectrophotometrically at 650 nm.
To minimize interassay variability, ELISA optical density values were normalized by using positive and negative control reagents assayed on each microdilution plate. The presence or absence of antibody to FIV was determined by Samples for the seroconversion studies were obtained from the Cornell Feline Health Center (Ithaca, N.Y.) and the University of California (Davis). These were obtained from specific-pathogen-free animals after inoculation with either infectious cell free tissue culture fluid (1 ml), FIV-infected whole blood (1 ml), or 0.44-,um-filtered plasma (2 ml) from infected animals.
Western blot assay. The Western blot (immunoblot) protocol used was a modification of the procedure initially described by Towbin et al. (23) . Purified FIV was disrupted with sodium dodecyl sulfate (SDS) and mercaptoethanol and separated with a 10% SDS-polyacrylamide gel. Viral proteins were transferred to nitrocellulose sheets, which were then blocked with detergent and calf serum. Individual strips were cut from each sheet and incubated for 2 h with a 1:100 dilution of sample prepared in a phosphate-buffered saline solution containing 0.05% Tween 20, 1% bovine serum albumin, and 30% calf serum. Strips were washed exhaustively with phosphate-buffered saline-0.05% Tween 20 and incubated for 1 h with goat anti-feline horseradish peroxidase conjugate. The wash cycle was repeated, and the precipitating substrate 4-chloronaphthol was added. Reactions were stopped by washing with deionized H20, and results were immediately interpreted. The presence of two or more FIV viral bands was necessary to confirm a sample as positive for antibody to FIV. The molecular weights of FIV-reactive peptides were determined by comparison of immunoperoxidase-stained Western blot strips with Coomassie blue-stained polyacrylamide gels and amido blackstained nitrocellulose strips (R. Steinman, T. O'Connor, Q. Tonelli, K. Lawrence, C. Seymour, J. Goodness, N. Pedersen, and P. R. Andersen, submitted for publication). Uninfected Crfk host cell extract was used to prepare Western blot strips to identify reactive bands unrelated to FIV infection. These were used in the identification of nonspecific bands appearing on FIV blot strips.
RIPA-SDS-PAGE. For the radioimmunoprecipitation assay (RIPA) with SDS-polyacrylamide gel electrophoresis (PAGE), the FIV productively growing in cell culture was metabolically labeled with [35S]methionine and [35S]cysteine at 37°C for 4 h. Cells were lysed in 10 mM phosphate buffer (pH 7.5) containing 100 mM NaCI, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 0.1 mM phenylmethylsulfonyl fluoride, and 100 Kallikren inactivator units of aprotinin per ml (lysis buffer). Cell lysates were clarified by centrifugation at 100,000 x g for 30 min before use. Generally, 100 ,ul of viral extract was mixed with 5 ,ul of serum sample and incubated for 18 h at 3°C. Samples were concentrated by adding 0.2 ml of a 5% suspension of protein A-Sepharose CL-4B (Pharmacia Fine Chemicals) in 10 mM phosphate (pH 7.5)-100 mM NaCl-1% Triton X-100-0.1% SDS and centrifuging. The pellet was washed three times in lysis buffer, heated in sample buffer, and applied to a 12% SDS-polyacrylamide gel (14). Gels were processed for fluorography and exposed at -70°C to Kodak XAR-5 film. (24) .
RESULTS

FIV
The Western blot assay of the two temporal series showed initial reaction to the FIV gag proteins piS and p26 (Fig. 2  and 3 (Fig. 4 and 5 ). FIV proteins immunoprecipitated by the temporal samples were identified as gpl3O, pilO, p47, gp4O, p36, and p22 (Steinman et ai., submitted). FIV ELISA: clinical evaluation. The frequency distributions for the clinic and sick cat populations are shown in Fig.   6 and 7, respectively. Results are plotted as frequency versus the S/P ratio. As described in Materials and Methods, an S/P ratio greater than 0.5 indicates that the sample contains significant levels of antibody to FIV. The seropositive rate was 5.2% for the clinic population (n = 957) and 15.2% for the sick cat population (n = 599). Western blot and/or RIPA-SDS-PAGE confirmatory assays were conducted on all samples that tested positive by the microdilution plate test. Each of these samples was positive by the confirmatory procedures. Western blot assays of FIV antibody-positive samples typically showed a strong reaction to the FIV gag proteins p26 and pi5 and variable reactivity to additional FIV proteins (10,000, 32,000, 40,000, 47,000, and 65,000 daltons) (Steinman et al., submitted). Staining of two or more FIV peptides was required for positive result confirmation by Western blotting, whereas reaction to gpl3O was required for confirmation by RIPA-SDS-PAGE. The RIPA-SDS-PAGE assays of positive samples demonstrated variable reactions to proteins of 130,000, 110,000, 47,000, 40,000, 36,000, 22,000, and 15,000 daltons; however, all plate test-positive samples immunoprecipitated gpl3O. A small percentage (3%) of microdilution plate test-positive samples were reactive to only a single FIV peptide (p26 or piS) in the Western blot assay. These samples were positive when tested using the RIPA-SDS-PAGE assay. A set of 150 plate test-negative samples were negative when tested by the Western blot assay. 
DISCUSSION
The seroconversion studies demonstrate that a significant antibody level to FIV can be measured 3 to 4 weeks after initial exposure to the virus. The long time course (13 to 
